XML 54 R44.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders’ Equity (Deficit), Temporary Equity and Noncontrolling Interests (Details) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Jun. 09, 2020
Jan. 15, 2020
Feb. 01, 2019
Jul. 31, 2020
Jun. 18, 2020
Feb. 29, 2020
Jan. 31, 2020
Dec. 23, 2019
Jun. 30, 2020
Sep. 30, 2020
May 31, 2020
Apr. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
May 14, 2019
Stockholders’ Equity (Deficit), Temporary Equity and Noncontrolling Interests (Details) [Line Items]                              
Preferred stock, shares authorized                   10,000,000       10,000,000  
Preferred stock, par value (in Dollars per share)                   $ 0.0001       $ 0.0001  
Preferred stock, shares issued                          
Gross proceeds from sale of units (in Dollars) $ 25,000                            
Common Stock, Shares Authorized                   250,000,000       250,000,000  
Value of shares issued (in Dollars)                   $ 1,929,516          
Included in accrued expenses (in Dollars)                   $ 2,238,314          
Common Stock, Par or Stated Value Per Share (in Dollars per share)                   $ 0.0001 $ 0.0001     $ 0.0001  
Common Stock, Shares, Issued                   5,131,508       3,619,658  
Common Stock, Shares, Outstanding                   5,131,508       3,619,658  
Recognized compensation expense (in Dollars)                   $ 318,473          
Restricted common stock shares         554,000                    
Maximum [Member]                              
Stockholders’ Equity (Deficit), Temporary Equity and Noncontrolling Interests (Details) [Line Items]                              
Common Stock, Shares Authorized                   250,000,000 31,250,000        
Minimum [Member]                              
Stockholders’ Equity (Deficit), Temporary Equity and Noncontrolling Interests (Details) [Line Items]                              
Common Stock, Shares Authorized                   31,250,000 250,000,000        
Mr. Sohn [Member]                              
Stockholders’ Equity (Deficit), Temporary Equity and Noncontrolling Interests (Details) [Line Items]                              
Common stock, description         The RSUs will vest over a two-year period from the date of the Uplisting in equal quarterly installments on the last day of each calendar quarter, with the first portion vesting on the last day of the calendar quarter during which the Uplisting takes place, subject to Mr. Sohn serving as an executive officer of the Company on each applicable vesting date, provided that the RSUs shall vest in full immediately upon the termination of Mr. Sohn’s employment by the Company without Cause (as defined in the Employment Agreement). The RSU award has been valued at $1,662,000 and compensation expense will be recorded over the estimated vesting period. We recognized compensation expense of $181,309 and $211,527 during the three and nine months ended September 30, 2020, respectively. The shares have not been issued at September 30, 2020                    
Preferred Stock [Member]                              
Stockholders’ Equity (Deficit), Temporary Equity and Noncontrolling Interests (Details) [Line Items]                              
Preferred stock, shares authorized                   10,000,000     200,000    
Preferred stock, par value (in Dollars per share)                   $ 0.0001          
Preferred stock, shares issued                   1,324,022       1,329,300  
Owed approximately penalties (in Dollars)                           $ 6,000,000  
Included in accrued expenses (in Dollars)                   $ 308,798          
Common Stock [Member]                              
Stockholders’ Equity (Deficit), Temporary Equity and Noncontrolling Interests (Details) [Line Items]                              
Shares issued       12,000                      
Shares of restricted common stock     43,423                        
Recognized compensation expense (in Dollars)                   $ 12,665          
Restricted common stock shares   30,000                         451,170
Common stock, description               the Company granted to a consultant 312,500 restricted stock units (the “RSUs”) pursuant to a consultant agreement. The RSUs vest 63,500 upon grant with the balance vesting monthly in equal installments beginning January 1, 2020 and ending November 1, 2020, subject to the consultants continued service to the Company on each vesting date. The RSU award has been valued at $343,750 and compensation expense will be recorded over the respective vesting periods. We recognized compensation expense of $74,999 and $224,997 during the three and nine months ended September 30, 2020, respectively. The shares have not been issued at September 30, 2020. The vested shares will be issued at the earlier of the final vesting period or the termination of services. Effective January 15, 2020 the Company entered into a consulting agreement. Pursuant to the agreement the Company agreed to issue 60,000 shares of restricted common stock, plus a payment of $15,000. The shares are fully vested upon issuance and have been valued at $75,000, based on the quoted market price of our common stock on the grant date. The shares were issued on April 3, 2020. We have recorded compensation expense of $6,250 and $75,000 for the share portion of the agreement during the three and nine months ended September 30, 2020, respectively, and expense of $1,250 and $15,000 for the cash portion during the three and nine months ended September 30, 2020, respectively. Effective January 15, 2020 the Company entered into a consulting agreement. Pursuant to the agreement the Company agreed to issue 30,000 shares of restricted common stock, earned monthly over the three month term of the agreement. The shares are fully vested upon issuance and have been valued at $45,500, based on the quoted market price of our common stock on the vesting dates. The shares were issued on April 3, 2020. We have recorded compensation expense of $0 and $45,500 during the three and nine months ended September 30, 2020, respectively. In January 2020, the Company issued 39,260 shares of its common stock upon conversion of 3,141 shares of Series E Preferred Stock. In January and February 2020, the Company issued 803,414 shares of its common stock upon conversion of 64,272 shares of Series F Preferred Stock. In February 2020, the Company issued 161,250 shares of its common stock upon conversion of 12,900 shares of its Series D Preferred Stock. In April 2020, the Company issued 138,926 shares of its common stock upon conversion of 11,114 shares of Series F Preferred Stock. In June 2020, the Company issued 157,000 shares of its common stock upon conversion of 12,560 shares of its Series D Preferred Stock. On June 18, 2020 the Company awarded to Mr. Sohn 554,000 restricted stock units (the “RSUs”) subject to and issuable upon the listing of the Company’s common stock on the Nasdaq Capital Market or NYSE American, or any successor of the foregoing (the “Uplisting”). The RSUs will vest over a two-year period from the date of the Uplisting in equal quarterly installments on the last day of each calendar quarter, with the first portion vesting on the last day of the calendar quarter during which the Uplisting takes place, subject to Mr. Sohn serving as an executive officer of the Company on each applicable vesting date, provided that the RSUs shall vest in full immediately upon the termination of Mr. Sohn’s employment by the Company without Cause (as defined in the Employment Agreement). The RSU award has been valued at $1,662,000 and compensation expense will be recorded over the estimated vesting period. We recognized compensation expense of $181,309 and $211,527 during the three and nine months ended September 30, 2020, respectively. The shares have not been issued at September 30, 2020.              
Common stock, description   Pursuant to the agreement the Company agreed to issue 30,000 shares of restricted common stock, earned monthly over the three month term of the agreement. The shares are fully vested upon issuance and have been valued at $45,500, based on the quoted market price of our common stock on the vesting dates. The shares were issued on April 3, 2020. We have recorded compensation expense of $0 and $45,500 during the three and nine months ended September 30, 2020, respectively.   the Company issued 12,000 shares of its common stock pursuant to a consulting agreement entered into in June 2020. The shares are fully vested upon issuance. The shares have been valued at $34,200 based on the quoted market price of our common stock. This expense was accrued at June 30, 2020.                      
Common Stock [Member] | Maximum [Member]                              
Stockholders’ Equity (Deficit), Temporary Equity and Noncontrolling Interests (Details) [Line Items]                              
Common Stock, Shares Authorized                     31,250,000        
Common Stock [Member] | Minimum [Member]                              
Stockholders’ Equity (Deficit), Temporary Equity and Noncontrolling Interests (Details) [Line Items]                              
Common Stock, Shares Authorized                     250,000,000        
Restricted Common Stock [Member]                              
Stockholders’ Equity (Deficit), Temporary Equity and Noncontrolling Interests (Details) [Line Items]                              
Common stock, description   Pursuant to the agreement the Company agreed to issue 60,000 shares of restricted common stock, plus a payment of $15,000. The shares are fully vested upon issuance and have been valued at $75,000, based on the quoted market price of our common stock on the grant date. The shares were issued on April 3, 2020. We have recorded compensation expense of $6,250 and $75,000 for the share portion of the agreement during the three and nine months ended September 30, 2020, respectively, and expense of $1,250 and $15,000 for the cash portion during the three and nine months ended September 30, 2020, respectively                          
Series D Preferred Stock [Member]                              
Stockholders’ Equity (Deficit), Temporary Equity and Noncontrolling Interests (Details) [Line Items]                              
Preferred stock, shares authorized                   2,000,000       2,000,000  
Preferred stock, par value (in Dollars per share)                   $ 0.0001       $ 0.0001  
Preferred stock, shares issued                   527,795       454,546  
Preferred stock as consideration for waivers of penalties                   106,134          
Number of shares issued upon conversion       110,000   161,250     157,000            
Aggregate additional shares           12,900                  
Sale of Stock, Description of Transaction the Company sold 1,375 Series D preferred stock units (the “Units”) at a purchase price of $18.1818 per Unit, taking into account a 10% discount, each Unit consisting of one share of Series D Preferred Stock and a warrant to purchase 6.25 shares of common stock, subject to adjustment as provided for therein. The Series D Preferred Stock sold in the financing converts into a minimum of 17,188 shares of common stock. The Company received gross proceeds of $25,000 from the sale of the Units. The 8,594 warrants are exercisable for five years from the issuance date at an exercise price of $4.80 per share, subject to adjustment as provided for therein.                            
Share of Series D Preferred Stock sold 1,375                            
Preferred shares converted       8,800         12,560            
Shares issued       110,000                      
Aggregate additional shares                   106,134     106,134    
Value of shares issued (in Dollars)                         $ 1,929,516    
Series E Preferred Stock [Member]                              
Stockholders’ Equity (Deficit), Temporary Equity and Noncontrolling Interests (Details) [Line Items]                              
Preferred stock, shares authorized                   775,000       775,000  
Preferred stock, par value (in Dollars per share)                   $ 0.0001       $ 0.0001  
Preferred stock, shares issued                   731,845       734,986  
Aggregate additional shares             3,141                
Shares issued             39,260                
Included in accrued expenses (in Dollars)                   $ 308,893          
Series F Preferred Stock [Member]                              
Stockholders’ Equity (Deficit), Temporary Equity and Noncontrolling Interests (Details) [Line Items]                              
Preferred stock, shares authorized                   200,000       200,000  
Preferred stock, par value (in Dollars per share)                   $ 0.0001       $ 0.0001  
Preferred stock, shares issued                   64,382       139,768  
Aggregate additional shares           64,272                  
Preferred shares converted                       11,114      
Shares issued           803,414           138,926